newsfilter
← Latest News
PR Newswire·

Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius...